DSGN · Design Therapeutics, Inc.
$12.02
+0.15 (+1.26%)
At close · Jul 29
Market Cap
$750.73M
Shares
62.46M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-11-18 | Logos Global Master Fund LP | Director | 120,000 | 2025-11-18 | BTIG, LLC |
| 2025-11-14 | Logos Global Master Fund LP | Director | 620,000 | 2025-11-14 | BTIG, LLC |
| 2025-11-07 | Logos Global Master Fund LP | Director | 415,000 | 2025-11-07 | BTIG, LLC |
| 2025-08-13 | Logos Global Master Fund LP | Director | 345,000 | 2025-08-13 | BTIG, LLC |
| 2025-08-13 | Logos Opportunities Fund II LP | Director | 217,627 | 2025-08-13 | BTIG, LLC |
| 2024-08-09 | Logos SPV 1 LP | Director | 814,874 | 2024-08-09 | BTIG, LLC |
Showing 1–6 of 6 filings
Key facts
CIK
1807120
CUSIP
25056L103
13F (30d)
20 filings
20 filers
Visit website
Investor relations